In the second part of his Pharma Commerce video interview, Franco Stevanato, CEO of Stevanato Group, describes how from FDA ...

On Thursday, Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH) reported fourth-quarter adjusted EPS of 92 cents, up from 88 cents a year ago, but missing the consensus of 94 cents. Amphastar is a ...

Amneal Pharmaceuticals (NYSE:NASDAQ:AMRX), a commercial-stage biopharmaceutical company with a market capitalization of $2.53 billion, has been positioning itself for a new phase of multi-year growth ...

Supply chains are being diversified and regionalized to mitigate global disruptions, with significant investments in US ...

These corporate actions come as Vincerx Pharma, headquartered in San Mateo, California, continues to navigate the competitive pharmaceutical industry, with a focus on developing treatments in its ...

AI emerged as a key differentiator in accelerating development timelines and enhancing clinical operations. Decentralized ...

Stressing the need for the restoration of Weighted R&D Deduction (up to 200%), he noted that it would significantly boost ...

Biomarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best biotech stocks to buy according to Wall Street analysts. On November 18, BioMarin Pharmaceutical (NASDAQ:BMRN) presented at the Jefferies ...

The year also reinforced a long-standing strength of Indian pharma: its ability to scale through strategic consolidation.